Location Arlington, Massachusetts, United States Regions Greater Boston Area, East Coast, New England Gender Male
LinkedIn View on LinkedIn
Dr. Tebbe is the head of the medicinal and computational chemistry groups at Forma. He is a demonstrated drug hunter with over 17 years of experience in drug discovery and development. Mark has expertise in the areas of infectious diseases, endocrine, and metabolism targets and has delivered clinical candidates in all of these areas. He has
extensive experience with structure guided drug design and is a co-inventor of Incivek ™ (Telaprevir), an HCV protease inhibitor discovered and developed during a collaboration between Vertex and Lilly. He has platform based experience with Cell Surface Receptors/GPCR’s (including ion channels), proteases, and other enzyme targets and has extensive experience in lead generation and target validation. Dr. Tebbe has held multiple leadership positions during his career including Head of Discovery Chemistry at the Lilly site in Hamburg, Germany, Head of Chemistry at the Lilly site in Research Triangle Park, North Carolina, and Manager of Global Operations for discovery chemistry at Lilly. He is also a trained Green Belt in Six Sigma and has worked as an independent consultant in the pharmaceutical industry. He obtained his undergraduate degree from the University of Notre Dame and his Ph.D. in organic chemistry from Stanford University. INCIVEK is a trademark of Vertex.
